Skip to main content
DNA Labs India

Oncomine Comprehensive Panel + Oncomine Tumor Mutation Burden (TMB)+ MSI + PDL1 Test

DNA Labs India | ISO 9001:2015 Certified

Oncomine Comprehensive Panel + Oncomine Tumor Mutation Burden (TMB)+ MSI + PDL1 Test

Short Name: Oncomine Panel + TMB + MSI + PDL1

Also known as: Comprehensive Cancer Panel, Oncomine TMB Test, MSI Testing, PDL1 Expression Test

Oncomine Comprehensive Panel + Oncomine Tumor Mutation Burden (TMB)+ MSI + PDL1 Test test available at DNA Labs India for ₹120,000. Uses NGS, Sanger Sequencing, IHC on Tumor tissue + Peripheral Blood samples. Results in 2-3 weeks. Free home collection in 300+ cities across India.

OncologyAdults🏠 Home Collection

✍️ Written By

🩺 Medically Reviewed By

Dr Pasupathy Arumugam

Dr Pasupathy Arumugam

Consultant Pathologist · Reg: 21521

Last reviewed: September 7, 2026

Overview

To provide a comprehensive genomic analysis of cancer for personalized treatment planning, including assessment of immunotherapy response predictors such as TMB, MSI, and PDL1.

Test Code
3126
Price
₹120,000
Sample Type
Tumor tissue + Peripheral Blood
Result Time
2-3 weeks
Fasting Required
No
Method
NGS, Sanger Sequencing, IHC
Step 1

Sample Collection

Ensure doctor's prescription is available. No specific preparation required.

Method: Biopsy and Venipuncture

Step 2

Laboratory Analysis

Tumor biopsy and blood draw will be performed by trained professionals.

Step 3

Report Delivery

Samples will be processed and analyzed in the laboratory.

Timeline: 2-3 weeks

Patient Instructions

1
Before the Test:Obtain doctor's prescription and schedule sample collection at a DNA Labs India center or via home collection.
2
During the Test:Sample collection (biopsy and blood draw) followed by laboratory analysis using NGS, Sanger Sequencing, and IHC.
3
After the Test:Wait for report generation and consult your oncologist for interpretation and treatment planning.

About This Test

Who Should Get This Test

To provide a comprehensive genomic analysis of cancer for personalized treatment planning, including assessment of immunotherapy response predictors such as TMB, MSI, and PDL1.

How to Prepare

  • Provide tumor tissue in paraffin blocks
  • Collect blood in EDTA vacutainer
  • Label samples correctly with patient details

Doctor's Notes

Reviewed by — MBBS, MD (Pathology) · Reg. No. 21521

"This panel provides a comprehensive genomic analysis to guide personalized cancer therapy, including immunotherapy eligibility assessment."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeTumor tissue + Peripheral Blood
Sample VolumeAs required
ContainerParaffin embedded tissue blocks + EDTA Vacutainer (3 ml)
Collection MethodBiopsy and Venipuncture

Sample Stability

Tissue samples stable at room temperature for 24 hours
Blood samples stable for 48 hours refrigerated
Sample Rejection Criteria:
  • Inadequate sample volume
  • Contaminated samples
  • Missing documentation or prescription

Understanding Your Results

Results will indicate the presence of genetic mutations, TMB level, MSI status, and PDL1 expression, which guide treatment decisions.
High TMB may indicate better response to immunotherapy
MSI-High tumors are often responsive to immunotherapy
PDL1 expression above 1% may suggest immunotherapy benefit
Specific mutations may indicate eligibility for targeted therapies
⚠️ When to Consult a Doctor:

Consult your oncologist to discuss the results and determine the best treatment plan based on the genomic profile.

Limitations

  • ⚠May not detect all mutations
  • ⚠Results may vary based on tumor heterogeneity
  • ⚠Not a standalone diagnostic tool

Risks & Considerations

  • ●Biopsy-related risks such as bleeding or infection
  • ●Blood draw risks like bruising or discomfort

Interfering Factors

  • ●Poor sample quality
  • ●Insufficient tumor content
  • ●Degraded DNA

Compare With Similar Tests

TestOncomine Comprehensive Panel + Oncomine Tumor Mutation Burden (TMB)+ MSI + PDL1FoundationOne CDxGuardant360
ComparisonOncomine Comprehensive Panel + Oncomine Tumor Mutation Burden (TMB)+ MSI + PDL1

Frequently Asked Questions

What is the Oncomine Comprehensive Panel?
It is a next-generation sequencing test that analyzes 161 cancer-related genes for mutations, copy number variations, and gene fusions.
What does Tumor Mutation Burden (TMB) testing measure?
TMB measures the number of mutations in tumor DNA, which can predict response to immunotherapy.
How is Microsatellite Instability (MSI) testing performed?
MSI testing detects errors in DNA replication using techniques like PCR or NGS to assess tumor instability.
What is PDL1 and why is it important in cancer treatment?
PDL1 is a protein on cancer cells that can inhibit immune response; its expression helps determine eligibility for immunotherapy.
What is the cost of the Oncomine Comprehensive Panel + TMB + MSI + PDL1 test?
The cost is INR 120000, including home sample collection across India.
How long does it take to receive the test results?
Results are typically available within 2-3 weeks after sample collection.
Is home sample collection available for this test?
Yes, DNA Labs India offers free home sample collection for online bookings in numerous cities across India.
What types of samples are required for this test?
Tumor tissue (paraffin-embedded blocks) and peripheral blood in an EDTA vacutainer are required.
Who is eligible for this test?
Patients diagnosed with cancer who need comprehensive genomic analysis for treatment planning, as recommended by their oncologist.
How accurate is the Oncomine Comprehensive Panel?
The test uses advanced NGS technology with high accuracy, but results should be interpreted in clinical context by a specialist.
Can this test be used for all types of cancer?
It is designed for a broad range of cancers, but applicability may vary; consult your doctor for specific cases.
What should I do after getting the test results?
Discuss the results with your oncologist to understand implications and plan personalized treatment options.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

B-Cell Rearrangement Detection Test

₹22,000

Acute Lymphoblastic Leukemia (ALL) Cytogenetics Panel Test

₹20,000

Epstein-Barr Virus Early RNA (EBER-ISH) In-Situ-Hybridization Test

₹6,000

OncoPro NCCN Lung Cancer Panel with PD-L1 Test

₹140,400

Acute Myeloid Leukemia (AML) Cytogenetics Panel Test

₹23,000

AML ETO t(8;21) Gene Rearrangement PCR Qualitative Test

₹6,000
For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

✓ Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

✓ DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.